Literature DB >> 31604804

The IL-12- and IL-23-Dependent NK Cell Response Is Essential for Protective Immunity against Secondary Toxoplasma gondii Infection.

Daria L Ivanova1, Tiffany M Mundhenke1, Jason P Gigley2.   

Abstract

NK cells can develop cell-intrinsic memory-like characteristics. Whether they develop these characteristics during Toxoplasma gondii infection is unknown. We addressed this question and dissected the mechanisms involved in secondary NK cell responses using a vaccine-challenge mouse model of T. gondii infection. NK cells were required for control of and survival after secondary T. gondii infection. NK cells increased in number at the reinfection site and produced IFN-γ. To test if these T. gondii experienced NK cells were intrinsically different from naive NK cells, we performed NK cell adoptive transfer into RAG2/cγ-chain-/- mice, NK cell fate mapping, and RAG1-/- mice vaccine-challenge experiments. Although NK cells contributed to immunity after reinfection, they did not develop cell-intrinsic memory-like characteristics after T. gondii vaccination. The mechanisms required for generating these secondary NK cell responses were investigated. Secondary NK cell responses were CD4+ or CD8+ T cell independent. Although IL-12 alone is required for NK cell IFN-γ production during primary T. gondii infection, in the absence of IL-12 using IL-12p35-/- mice or anti-IL-12p70, secondary NK cell responses were only partially reduced after reinfection. IL-23 depletion with anti-IL-23p19 in vivo also significantly reduced the secondary NK cell response. IL-12 and IL-23 blockade with anti-IL-12p40 treatment completely eliminated secondary NK cell responses. Importantly, blockade of IL-12, IL-23, or both significantly reduced control of parasite reinfection and increased parasite burden. Our results define a previously unknown protective role for NK cells during secondary T. gondii infection that is dependent on IL-12 and IL-23.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31604804      PMCID: PMC6864276          DOI: 10.4049/jimmunol.1801525

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

1.  NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination.

Authors:  Amir Horowitz; Ron H Behrens; Lucy Okell; Anthony R Fooks; Eleanor M Riley
Journal:  J Immunol       Date:  2010-08-02       Impact factor: 5.422

Review 2.  IL-12p40: an inherently agonistic cytokine.

Authors:  Andrea M Cooper; Shabaana A Khader
Journal:  Trends Immunol       Date:  2006-11-28       Impact factor: 16.687

3.  Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii.

Authors:  W E Hauser; S D Sharma; J S Remington
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

4.  A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.

Authors:  F Mazurier; A Fontanellas; S Salesse; L Taine; S Landriau; F Moreau-Gaudry; J Reiffers; B Peault; J P Di Santo; H de Verneuil
Journal:  J Interferon Cytokine Res       Date:  1999-05       Impact factor: 2.607

Review 5.  Memory responses by natural killer cells.

Authors:  Aimee M Beaulieu
Journal:  J Leukoc Biol       Date:  2018-08-29       Impact factor: 4.962

6.  Genital HSV-2 infection induces short-term NK cell memory.

Authors:  Mohamed F Abdul-Careem; Amanda J Lee; Elishka A Pek; Navkiran Gill; Amy E Gillgrass; Marianne V Chew; Sarah Reid; Ali A Ashkar
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

7.  Proinflammatory cytokine signaling required for the generation of natural killer cell memory.

Authors:  Joseph C Sun; Sharline Madera; Natalie A Bezman; Joshua N Beilke; Mark H Kaplan; Lewis L Lanier
Journal:  J Exp Med       Date:  2012-04-09       Impact factor: 14.307

8.  Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.

Authors:  Jaroslav Flegr; Joseph Prandota; Michaela Sovičková; Zafar H Israili
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.

Authors:  Lisa L Liu; Johannes Landskron; Eivind H Ask; Monika Enqvist; Ebba Sohlberg; James A Traherne; Quirin Hammer; Jodie P Goodridge; Stella Larsson; Jyothi Jayaraman; Vincent Y S Oei; Marie Schaffer; Kjetil Taskén; Hans-Gustaf Ljunggren; Chiara Romagnani; John Trowsdale; Karl-Johan Malmberg; Vivien Béziat
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

Review 10.  Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.

Authors:  Nayoung Kim; Hun Sik Kim
Journal:  Front Immunol       Date:  2018-09-10       Impact factor: 7.561

View more
  12 in total

Review 1.  Fate-mapping mice: new tools and technology for immune discovery.

Authors:  Scarlett E Lee; Brian D Rudd; Norah L Smith
Journal:  Trends Immunol       Date:  2022-01-31       Impact factor: 16.687

2.  IL-12 from endogenous cDC1, and not vaccine DC, is required for Th1 induction.

Authors:  DiyaaElDin Ashour; Panagiota Arampatzi; Vladimir Pavlovic; Konrad U Förstner; Tsuneyasu Kaisho; Andreas Beilhack; Florian Erhard; Manfred B Lutz
Journal:  JCI Insight       Date:  2020-05-21

3.  Anti-infection roles of miR-155-5p packaged in exosomes secreted by dendritic cells infected with Toxoplasma gondii.

Authors:  Dan Jiang; Shuizhen Wu; Liqing Xu; Guantai Xie; Dongliang Li; Hongjuan Peng
Journal:  Parasit Vectors       Date:  2022-01-06       Impact factor: 3.876

4.  IL-23 orchestrating immune cell activation in arthritis.

Authors:  Aurélie Najm; Iain B McInnes
Journal:  Rheumatology (Oxford)       Date:  2021-10-19       Impact factor: 7.580

5.  A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis.

Authors:  Xiaowei Tian; Hanqi Sun; Meng Wang; Guangmin Wan; Tong Xie; Xuefang Mei; Zhenchao Zhang; Xiangrui Li; Shuai Wang
Journal:  Front Vet Sci       Date:  2022-02-15

Review 6.  Reprogramming the tumor microenvironment by genome editing for precision cancer therapy.

Authors:  Ke Liu; Jia-Jia Cui; Yan Zhan; Qian-Ying Ouyang; Qi-Si Lu; Dong-Hua Yang; Xiang-Ping Li; Ji-Ye Yin
Journal:  Mol Cancer       Date:  2022-04-11       Impact factor: 27.401

7.  C5aR1 Activation Drives Early IFN-γ Production to Control Experimental Toxoplasma gondii Infection.

Authors:  Daria Briukhovetska; Birte Ohm; Fabian T Mey; Julio Aliberti; Marie Kleingarn; Markus Huber-Lang; Christian M Karsten; Jörg Köhl
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

8.  NK Cells Negatively Regulate CD8 T Cells to Promote Immune Exhaustion and Chronic Toxoplasma gondii Infection.

Authors:  Daria L Ivanova; Ryan Krempels; Stephen L Denton; Kevin D Fettel; Giandor M Saltz; David Rach; Rida Fatima; Tiffany Mundhenke; Joshua Materi; Ildiko R Dunay; Jason P Gigley
Journal:  Front Cell Infect Microbiol       Date:  2020-07-08       Impact factor: 5.293

Review 9.  Memory and Memory-Like NK Cell Responses to Microbial Pathogens.

Authors:  Marc Brillantes; Aimee M Beaulieu
Journal:  Front Cell Infect Microbiol       Date:  2020-03-25       Impact factor: 5.293

10.  IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells.

Authors:  Andreas A Hombach; Ulf Geumann; Christine Günther; Felix G Hermann; Hinrich Abken
Journal:  Cells       Date:  2020-04-03       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.